Roivant Sciences Statistics
Total Valuation
ROIV has a market cap or net worth of $25.02 billion. The enterprise value is $21.29 billion.
| Market Cap | 25.02B |
| Enterprise Value | 21.29B |
Important Dates
The last earnings date was Thursday, August 6, 2026, before market open.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ROIV has 722.32 million shares outstanding. The number of shares has decreased by -1.06% in one year.
| Current Share Class | 722.32M |
| Shares Outstanding | 722.32M |
| Shares Change (YoY) | -1.06% |
| Shares Change (QoQ) | -11.27% |
| Owned by Insiders (%) | 18.94% |
| Owned by Institutions (%) | 77.70% |
| Float | 580.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3,322.00 |
| Forward PS | 251.91 |
| PB Ratio | 5.92 |
| P/TBV Ratio | 5.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2,826.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.72, with a Debt / Equity ratio of 0.02.
| Current Ratio | 16.72 |
| Quick Ratio | 13.62 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -8.52% and return on invested capital (ROIC) is -118.82%.
| Return on Equity (ROE) | -8.52% |
| Return on Assets (ROA) | -16.48% |
| Return on Invested Capital (ROIC) | -118.82% |
| Return on Capital Employed (ROCE) | -27.15% |
| Weighted Average Cost of Capital (WACC) | 10.40% |
| Revenue Per Employee | $10,447 |
| Profits Per Employee | -$369,283 |
| Employee Count | 721 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ROIV has paid $124.72 million in taxes.
| Income Tax | 124.72M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +190.36% in the last 52 weeks. The beta is 1.13, so ROIV's price volatility has been higher than the market average.
| Beta (5Y) | 1.13 |
| 52-Week Price Change | +190.36% |
| 50-Day Moving Average | 35.15 |
| 200-Day Moving Average | 28.21 |
| Relative Strength Index (RSI) | 43.92 |
| Average Volume (20 Days) | 7,624,645 |
Short Selling Information
The latest short interest is 30.60 million, so 4.24% of the outstanding shares have been sold short.
| Short Interest | 30.60M |
| Short Previous Month | 35.23M |
| Short % of Shares Out | 4.24% |
| Short % of Float | 5.27% |
| Short Ratio (days to cover) | 6.00 |
Income Statement
In the last 12 months, ROIV had revenue of $7.53 million and -$266.25 million in losses. Loss per share was -$0.49.
| Revenue | 7.53M |
| Gross Profit | -723.89M |
| Operating Income | -1.36B |
| Pretax Income | -289.88M |
| Net Income | -266.25M |
| EBITDA | -1.36B |
| EBIT | -1.36B |
| Loss Per Share | -$0.49 |
Balance Sheet
The company has $3.84 billion in cash and $107.15 million in debt, with a net cash position of $3.73 billion or $5.17 per share.
| Cash & Cash Equivalents | 3.84B |
| Total Debt | 107.15M |
| Net Cash | 3.73B |
| Net Cash Per Share | $5.17 |
| Equity (Book Value) | 4.92B |
| Book Value Per Share | 5.86 |
| Working Capital | 4.46B |
Cash Flow
In the last 12 months, operating cash flow was -$816.47 million and capital expenditures -$4.59 million, giving a free cash flow of -$821.06 million.
| Operating Cash Flow | -816.47M |
| Capital Expenditures | -4.59M |
| Depreciation & Amortization | 2.85M |
| Net Borrowing | n/a |
| Free Cash Flow | -821.06M |
| FCF Per Share | -$1.14 |
Margins
| Gross Margin | n/a |
| Operating Margin | -18,102.46% |
| Pretax Margin | -3,848.65% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ROIV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.06% |
| Shareholder Yield | 1.06% |
| Earnings Yield | -1.06% |
| FCF Yield | -3.28% |
Analyst Forecast
The average price target for ROIV is $41.82, which is 20.73% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $41.82 |
| Price Target Difference | 20.73% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 468.61% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ROIV has an Altman Z-Score of 23.8.
| Altman Z-Score | 23.8 |
| Piotroski F-Score | n/a |